Tailored vaccine shows promise in preventing cancer return
NCT ID NCT07504484
First seen Apr 04, 2026 · Last updated Jun 16, 2026 · Updated 13 times
Summary
This study tested a personalized vaccine made from unique markers in each patient's tumor. It was given after standard surgery and chemotherapy to 6 people with stage III colorectal or lung cancer. The goal was to see if it was safe and could help prevent the cancer from coming back. The vaccine was well tolerated, and researchers monitored patients for side effects and cancer recurrence over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.